Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Ruxolitinib treatment may cause eyelash growth.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted cancer therapies often cause serious skin problems that need careful management.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Psychotropic medications can cause skin problems but also treat some skin conditions.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Some alternative treatments for hair loss might work, but more research is needed.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.